Cathepsin E Protein

Cathepsin E Protein

Overview

Cathepsin E (CTSE) is an aspartic protease belonging to the cathepsin family of lysosomal hydrolases. As a pepsin-like protease, it functions primarily within acidic cellular compartments, particularly lysosomes and late endosomes. The CTSE gene is located on chromosome 1q31.1 and encodes a protein of approximately 406 amino acids. Cathepsin E is distinguished from other cathepsins by its acidic pH optimum (pH 3.0-4.0) and its dual catalytic activity within the lysosomal degradation pathway. While widely distributed across tissues, cathepsin E shows particularly high expression in the brain, stomach, and immune cells. In neural tissue, it is present in both neurons and glial cells, where it participates in protein homeostasis and cellular quality control mechanisms.

Function/Biology

Cathepsin E operates as a lysosomal endopeptidase, catalyzing the hydrolysis of peptide bonds in proteins and peptide substrates within the acidic environment of lysosomes. The enzyme is synthesized as an inactive proform (procathepsin E) and undergoes proteolytic maturation through sequential cleavage events mediated by other proteases, ultimately generating the active 34 kDa catalytic form. In its mature state, cathepsin E contains two conserved aspartic acid residues within its active site that are essential for catalytic activity—a structural feature characteristic of aspartic proteases.

Cathepsin E Protein

Overview

Cathepsin E (CTSE) is an aspartic protease belonging to the cathepsin family of lysosomal hydrolases. As a pepsin-like protease, it functions primarily within acidic cellular compartments, particularly lysosomes and late endosomes. The CTSE gene is located on chromosome 1q31.1 and encodes a protein of approximately 406 amino acids. Cathepsin E is distinguished from other cathepsins by its acidic pH optimum (pH 3.0-4.0) and its dual catalytic activity within the lysosomal degradation pathway. While widely distributed across tissues, cathepsin E shows particularly high expression in the brain, stomach, and immune cells. In neural tissue, it is present in both neurons and glial cells, where it participates in protein homeostasis and cellular quality control mechanisms.

Function/Biology

Cathepsin E operates as a lysosomal endopeptidase, catalyzing the hydrolysis of peptide bonds in proteins and peptide substrates within the acidic environment of lysosomes. The enzyme is synthesized as an inactive proform (procathepsin E) and undergoes proteolytic maturation through sequential cleavage events mediated by other proteases, ultimately generating the active 34 kDa catalytic form. In its mature state, cathepsin E contains two conserved aspartic acid residues within its active site that are essential for catalytic activity—a structural feature characteristic of aspartic proteases.

The protein functions as a component of the endo-lysosomal proteolytic cascade, which includes other cathepsins (cathepsins B, D, and L) that collectively execute the degradation of proteins destined for lysosomal disposal. Cathepsin E exhibits broad substrate specificity and preferentially cleaves peptide bonds adjacent to hydrophobic residues. Beyond its canonical role in protein degradation, cathepsin E participates in the processing of bioactive peptides and the inactivation of neuropeptides within vesicular compartments. Recent evidence suggests cathepsin E may also function in immune regulation, as it is highly expressed in cells of the immune system and capable of processing immune mediators.

Role in Neurodegeneration

Cathepsin E dysregulation has been implicated in multiple neurodegenerative conditions, particularly those characterized by protein aggregation and impaired protein degradation. In Alzheimer's disease, altered cathepsin E activity correlates with aberrant processing of the amyloid precursor protein (APP) and generation of amyloid-beta peptides, although the direction of this relationship—whether elevated or diminished activity contributes to pathology—remains incompletely understood. The enzyme's ability to process tau protein and regulate its clearance suggests involvement in tau pathology development.

In Parkinson's disease and other synucleinopathies, cathepsin E dysfunction may compromise the degradation of alpha-synuclein aggregates, potentially allowing accumulation of pathological protein species within lysosomes. The reduced clearance of misfolded proteins can trigger lysosomal dysfunction and neuroinflammation. Genetic variations affecting cathepsin E expression or activity may influence individual susceptibility to these diseases, making it a potential genetic risk modifier in neurodegeneration.

Molecular Mechanisms

Cathepsin E participates in neurodegeneration through several interconnected mechanisms. First, impaired activity reduces the capacity for protein aggregation clearance within lysosomes, exacerbating the accumulation of pathological protein conformers. Second, dysregulated cathepsin E can trigger inappropriate cleavage events, generating neurotoxic peptide fragments. Third, cathepsin E dysfunction correlates with lysosomal membrane permeabilization and leakage of proteases into the cytoplasm, activating apoptotic cascades.

The enzyme's activity is regulated by endogenous inhibitors (cystatins) and pH conditions; alterations in lysosomal acidification common to neurodegenerative diseases can secondarily affect cathepsin E function. Additionally, cathepsin E may process neuroinflammatory mediators; dysregulation could amplify glial activation and neuroinflammation characteristic of neurodegeneration.

Clinical/Research Significance

Cathepsin E represents both a potential biomarker and therapeutic target in neurodegeneration research. Cerebrospinal fluid cathepsin E levels may reflect lysosomal dysfunction severity. Modulation of cathepsin E activity through selective inhibitors or genetic approaches is being explored to enhance protein degradation capacity in disease models. Understanding cathepsin E biology is particularly relevant for lysosomal storage disorders and age-related neurodegeneration.

Related Entities

• Cathepsin D: aspartic protease with overlapping substrate specificity
• Cathepsin B: cysteine protease; complementary lysosomal degradation pathway
• Amyloid Precursor Protein (APP): substrate for cathepsin E processing
• Alpha-synuclein: protein whose clearance involves cathepsin E
• Lysosomal dysfunction: central to cathepsin E pathophysiology
• Autophagy: pathway utilizing cathepsin E for proteolysis